DEVELOPMENT OF DIABETES MELLITUS SEVERAL YEARS AFTER MANIFESTATION OF DIABETIC NEPHROPATHY: CASE REPORT AND REVIEW OF LITERATURE

2003 ◽  
Vol 9 (4) ◽  
pp. 301-306 ◽  
Author(s):  
Elias S. Siraj, MD ◽  
Jonathan Myles, MD ◽  
Saul Nurko, MD ◽  
Adi E. Mehta, MD, FRCP, FACE ◽  
S. Sethu K. Reddy, MD, FRCPC, FACP, FACE
Keyword(s):  
Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Case Report ◽  
Review Of Literature

DIABETES MELLITUS AS THE PRESENTING FEATURE OF EXTRAHEPATIC CHOLANGIOCARCINOMA IN SITU: CASE REPORT AND REVIEW OF LITERATURE

2004 ◽  
Vol 10 (5) ◽  
pp. 417-423 ◽  
Author(s):  
Daniel B. Costa ◽  
Andrew A. Chen ◽  
Esmeralda C. Marginean ◽  
Silvio E. Inzucchi
Keyword(s):  
Diabetes Mellitus ◽  
Case Report ◽  
Review Of Literature ◽  
Extrahepatic Cholangiocarcinoma

scholarly journals A Case Report on Diabetes Mellitus Type 1 with Left Kidney Fungal Ball With Diabetic Nephropathy.

2017 ◽  
Vol 16 (2) ◽  
pp. 01-02
Author(s):  
Dr. Bharat Veer Manchanda ◽  
Dr. Girish Dubey ◽  
Dr. Saloni Mehra ◽  
Dr. Umesh Verma ◽  
Dr. Saminder Chaudhary ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Case Report ◽  
Left Kidney ◽  
Diabetes Mellitus Type 1 ◽  
Diabetes Mellitus Type ◽  
Fungal Ball

Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature

2019 ◽  
Vol 15 (4) ◽  
pp. 259-262 ◽  
Author(s):  
Carlos Hernandez-Quiles ◽  
Nieves Ramirez-Duque ◽  
Domingo Acosta-Delgado
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Case Report ◽  
Paradigm Shift ◽  
Cardiovascular Events ◽  
Sglt2 Inhibitors ◽  
Review Of Literature ◽  
Sodium Glucose Cotransporter ◽  
Increased Risk

Introduction: Sodium-glucose cotransporter 2(SGLT2)-inhibitors are new antihyperglycemic agents that have shown a reduction in cardiovascular events in type 2 diabetes mellitus. Recent warnings have been developed about an increased risk of euglycemic and moderate hyperglycemic diabetic ketoacidosis with the use of SGLT2 inhibitors, but its real incidence is not available yet. Case Report: We present a case of DKA with moderate hyperglycemia in a patient treated with metformin and empagliflozin. Conclusion: DKA in patients treated with SGLT2 inhibitors can be presented as euglycemic and moderated hyperglycemia. This special presentation poses a physician’s challenge.

scholarly journals Diabetic Nephropathy Simulating Autoimmune-Related Glomerulonephritis: A Case Report

2021 ◽  
Vol 7 (2) ◽  
pp. 1-4
Author(s):  
Shih-Chung Hsieh ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Case Report ◽  
Chronic Inflammation ◽  
Blood Sugar ◽  
Biological Tissue ◽  
Tissue Destruction

In patients with type 2 diabetes mellitus, physiological autoimmunity is seemingly activated by chronic inflammation primarily because of blood sugar deposition, resulting in biological tissue destruction.

scholarly journals EMPHYSEMATOUS PYELONEPHRITIS AND HEPATIC HEMANGIOMA IN A PATIENT WITH DIABETES MELLITUS CASE REPORT AND REVIEW OF LITERATURE

2018 ◽  
Vol 18 (3) ◽  
Author(s):  
Miguel Trillo Ramos ◽  
Victor Bazán Álvarez ◽  
Ítalo Valero Román ◽  
Luis Celis Ruiz ◽  
Raquel Román Huamán
Keyword(s):  
Diabetes Mellitus ◽  
Case Report ◽  
Hepatic Hemangioma ◽  
Review Of Literature ◽  
Emphysematous Pyelonephritis
Sign in / Sign up

Export Citation Format

Share Document